Two Sigma Advisers’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,400
Closed -$34.1K 2782
2023
Q1
$34.1K Hold
11,400
﹤0.01% 2480
2022
Q4
$34.1K Hold
11,400
﹤0.01% 2392
2022
Q3
$34K Hold
11,400
﹤0.01% 2407
2022
Q2
$34K Sell
11,400
-100
-0.9% -$310 ﹤0.01% 2512
2022
Q1
$44K Sell
11,500
-1,900
-14% -$7.89K ﹤0.01% 2601
2021
Q4
$56K Buy
13,400
+1,000
+8% +$4.25K ﹤0.01% 2465
2021
Q3
$58K Buy
+12,400
New +$60.8K ﹤0.01% 2361
2020
Q3
Sell
-46,378
Closed -$144K 2747
2020
Q2
$144K Sell
46,378
-200
-0.4% -$581 ﹤0.01% 2309
2020
Q1
$148K Sell
46,578
-700
-1% -$3.06K ﹤0.01% 2245
2019
Q4
$236K Sell
47,278
-6,400
-12% -$30.6K ﹤0.01% 2132
2019
Q3
$260K Sell
53,678
-1,200
-2% -$6.29K ﹤0.01% 1969
2019
Q2
$317K Sell
54,878
-20,709
-27% -$137K ﹤0.01% 1994
2019
Q1
$531K Buy
75,587
+9,209
+14% +$60.9K ﹤0.01% 1775
2018
Q4
$428K Sell
66,378
-15,609
-19% -$99.7K ﹤0.01% 1834
2018
Q3
$573K Buy
81,987
+13,487
+20% +$101K ﹤0.01% 1739
2018
Q2
$650K Sell
68,500
-44,800
-40% -$429K ﹤0.01% 1812
2018
Q1
$1.16M Sell
113,300
-39,700
-26% -$406K ﹤0.01% 1484
2017
Q4
$1.52M Buy
153,000
+8,948
+6% +$97.8K ﹤0.01% 1366
2017
Q3
$1.6M Buy
144,052
+120,452
+510% +$1.41M ﹤0.01% 1314
2017
Q2
$224K Buy
+23,600
New +$188K ﹤0.01% 2086
2016
Q4
Sell
-10,400
Closed -$53K 2515
2016
Q3
$53K Sell
10,400
-100
-1% -$533 ﹤0.01% 2170
2016
Q2
$60K Sell
10,500
-600
-5% -$3.65K ﹤0.01% 2005
2016
Q1
$67K Sell
11,100
-23,300
-68% -$139K ﹤0.01% 1976
2015
Q4
$219K Sell
34,400
-7,502
-18% -$47.4K ﹤0.01% 1633
2015
Q3
$254K Buy
+41,902
New +$260K ﹤0.01% 1558

Other funds holding CO

Two Sigma Advisers's CO Position: Q2 2023 in Review

Two Sigma Advisers sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 11,400 shares — an estimated $34.1K sold.

Two Sigma Advisers first reported a position in CO in Q3 2015 and held it in 25 quarters. The position peaked at $1.6M in Q3 2017. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • Two Sigma Advisers reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 11,400 Global Cord Blood Corporation shares in Q2 2023, an estimated $34.1K.
  • Two Sigma Advisers first reported a position in Global Cord Blood Corporation in Q3 2015 and held it in 25 quarters.
  • Two Sigma Advisers's Global Cord Blood Corporation position peaked at $1.6M in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.